Feedback notes the proliferation of AI company logos, and agrees with one blogger's claim that many bear a striking ...

Roche has claimed a breakthrough designation from the FDA for a cancer test that combines an antibody assay with ...

CS Genetics, a leader in single cell genomics, is proud to announce the appointment of Paul McEwan as an Independent Director to its Board. Mr. McEwan brings over two decades of experience in life ...

Drugs giant Roche said it would invest $50 billion in the U.S. over the next five years as they grapple with Donald Trump’s ...

Roche posted higher sales that beat analysts’ expectations on higher demand for its key drugs.

Swiss drugmaker Roche said on Thursday its first-quarter sales rose a forecast-beating 7% driven by breast cancer drug Phesgo ...

Roche on Tuesday said it will invest $50 billion in the United States over the next five years, in one of the biggest inward ...

HEMLIBRA has strong market potential due to its unique, subcutaneous prophylactic treatment for Hemophilia A, including patients with and without factor VIII inhibitors. With increasing global ...

Developed by Chugai Pharmaceutical Co., Ltd., HEMLIBRA is co-developed internationally by Chugai, Roche, and Genentech. In ...

Decoy Therapeutics, Inc. (Decoy), a privately held preclinical biopharmaceutical company engineering the next generation of peptide conjugate therapeutics, announces that Massachusetts Institute of ...

This is an extraordinary technological leap in genetic engineering efforts for both science and for conservation as well as preservation of life, and a wonderful example of the power of ...

© 2025 NBCUniversal Media, LLCApple®, Apple logo® and App Store® are registered trademarks of Apple Inc.